Price negotiations [Off Topic]
I wonder if Scott Adams has a relative who works in the pharmaceutical industry and who is tasked with getting quotations from CROs on a frequent basis?
if (3) 4
"(...) targeted cancer therapies will benefit fewer than 2 percent of the cancer patients they’re aimed at. That reality is often lost on consumers, who are being fed a steady diet of winning anecdotes about miracle cures." New York Times (ed.), June 9, 2018.